Xspray Pharma Balance Sheet Health
Financial Health criteria checks 4/6
Xspray Pharma has a total shareholder equity of SEK625.2M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK705.4M and SEK80.3M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
Interest coverage ratio | n/a |
Cash | kr104.16m |
Equity | kr625.16m |
Total liabilities | kr80.25m |
Total assets | kr705.41m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: XSPRAS's short term assets (SEK154.9M) exceed its short term liabilities (SEK49.7M).
Long Term Liabilities: XSPRAS's short term assets (SEK154.9M) exceed its long term liabilities (SEK30.6M).
Debt to Equity History and Analysis
Debt Level: XSPRAS is debt free.
Reducing Debt: XSPRAS has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: XSPRAS has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: XSPRAS has less than a year of cash runway if free cash flow continues to reduce at historical rates of 23.6% each year